IP Library › Granted Patent US 10,626,430
Granted Patent B2
US 10,626,430 · App. 15/544,316 · Granted Apr 21, 2020

Method for preparing mogroside having no β-1,6-glucoside bond

Inventors: Misa Ochiai (Kyoto, JP); Eiichiro Ono (Kyoto, JP)
Assignee: SUNTORY HOLDINGS LIMITED
C12P19/44C12N9/2445C12N15/09C07K2319/02C12N9/24
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,626,430
App. No.
15/544,316
Granted
Apr 21, 2020
Kind
B2
Abstract

The present invention provides a method for preparing a mogroside having no β-1,6-glucoside bond comprising the step of reacting glycosidase ASBGL2, AOBGL2, AOBGL1, ASBGL1, or a variant thereof with a mogroside having at least one β-1,6-glucoside bond, thereby cleaving said β-1,6-glucoside bond.

Claims (32)

1. A method for preparing a mogroside having no β-1,6-glucoside bond comprising reacting a protein selected from the group consisting of proteins (a) to (c) shown below with a mogroside having at least one β-1,6-glucoside bond, thereby cleaving said β-1,6-glucoside bond:

(a) a protein having an amino acid sequence selected from the group consisting of SEQ ID NO: 4 and SEQ ID NO: 8;

(b) a protein having an amino acid sequence selected from the group consisting of SEQ ID NO: 4 and SEQ ID NO: 8, wherein 1 to 42 amino acids have been deleted, substituted, inserted, and/or added, and having an activity to cleave a β-1,6-glucoside bond of a mogroside; and

(c) a protein having an amino acid sequence having 95% or more sequence identity to an amino acid sequence selected from the group consisting of SEQ ID NO: 4 and SEQ ID NO: 8, and having an activity to cleave a β-1,6-glucoside bond of a mogroside.

2. The method according to claim 1 , wherein the protein selected from the group consisting of proteins (a) to (c) further includes a secretory signal peptide.

3. The method according to claim 1 , wherein the mogroside having at least one β-1,6-glucoside bond further has at least one β-1,2-glucoside bond.

4. The method according to claim 3 , wherein the mogroside having at least one β-1,6-glucoside bond and at least one β-1,2-glucoside bond is selected from mogroside V, siamenoside I, mogroside IV, and mogroside IIIA 1 .

5. The method according to claim 1 , wherein the mogroside having no β-1,6-glucoside bond is selected from mogroside IIIE and mogroside IIA.

6. A method for producing a mogroside having no β-1,6-glucoside bond comprising culturing a non-human transformant obtained by introducing a polynucleotide selected from the group consisting of polynucleotides (a) to (d) shown below into a host producing a mogroside having at least one β-1,6-glucoside bond:

(a) a polynucleotide having a nucleotide sequence selected from the group consisting of positions 61 to 2601 of SEQ ID NO: 1, positions 61 to 2707 of SEQ ID NO: 2, positions 61 to 2601 of SEQ ID NO: 5 and positions 61 to 2708 of SEQ ID NO: 6;

(b) a polynucleotide encoding a protein having an amino acid sequence selected from the group consisting of SEQ ID NO: 4 and SEQ ID NO: 8;

(c) a polynucleotide encoding a protein having an amino acid sequence selected from the group consisting of SEQ ID NO: 4 and SEQ ID NO: 8, wherein 1 to 42 amino acids have been deleted, substituted, inserted, and/or added, and having an activity to cleave a β-1,6-glucoside bond of a mogroside; and

(d) a polynucleotide encoding a protein having an amino acid sequence having 95% or more sequence identity to an amino acid sequence selected from the group consisting of SEQ ID NO: 4 and SEQ ID NO: 8, and having an activity to cleave a β-1,6-glucoside bond of a mogroside.

7. The method according to claim 6 , wherein the polynucleotide selected from the group consisting of polynucleotides (a) to (d) further includes a polynucleotide consisting of a nucleotide sequence encoding a secretory signal peptide.

8. The method according to claim 7 , wherein the polynucleotide consisting of a nucleotide sequence encoding a secretory signal peptide is a polynucleotide consisting of a nucleotide sequence set forth in any of positions 1 to 60 of SEQ ID NO: 1, positions 1 to 60 of SEQ ID NO: 5, positions 1 to 57 of SEQ ID NO: 9, positions 1 to 57 of SEQ ID NO: 13, SEQ ID NO: 43, SEQ ID NO: 45, and SEQ ID NO: 47.

9. The method according to claim 8 , wherein the polynucleotide containing the polynucleotide consisting of a nucleotide sequence encoding a secretory signal peptide consists of a nucleotide sequence set forth in any of SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 5, SEQ ID NO: 6, and SEQ ID NOS: 17 to 19.

10. The method according to claim 6 , wherein the polynucleotide is inserted into an expression vector.

11. The method according to claim 6 , wherein the transformant is transformed yeast or a transformed plant.

12. A method for preparing a mogroside having no β-1,6-glucoside bond comprising contacting an enzyme agent derived from a non-human transformed cell obtained by introducing, into a host cell, a polynucleotide selected from the group consisting of polynucleotides (a) to (d) shown below, with a mogroside having at least one β-1,6-glucoside bond, thereby cleaving said β-1,6-glucoside bond:

(a) a polynucleotide having a nucleotide sequence selected from the group consisting of positions 61 to 2601 of SEQ ID NO: 1, positions 61 to 2707 of SEQ ID NO: 2, positions 61 to 2601 of SEQ ID NO: 5, and positions 61 to 2708 of SEQ ID NO: 6;

(b) a polynucleotide encoding a protein having an amino acid sequence selected from the group consisting of SEQ ID NO: 4 and SEQ ID NO: 8;

(c) a polynucleotide encoding a protein having an amino acid sequence selected from the group consisting of SEQ ID NO: 4 and SEQ ID NO: 8, wherein 1 to 42 amino acids have been deleted, substituted, inserted, and/or added, and having an activity to cleave a β-1,6-glucoside bond of a mogroside; and

(d) a polynucleotide encoding a protein having an amino acid sequence having 95% or more sequence identity to an amino acid sequence selected from the group consisting of SEQ ID NO: 4 and SEQ ID NO: 8, and having an activity to cleave a β-1,6-glucoside bond of a mogroside.

13. The method according to claim 12 , wherein the polynucleotide selected from the group consisting of polynucleotides (a) to (d) further includes a polynucleotide consisting of a nucleotide sequence encoding a secretory signal peptide.

14. The method according to claim 13 , wherein the polynucleotide consisting of a nucleotide sequence encoding a secretory signal peptide is a polynucleotide consisting of a nucleotide sequence set forth in any of positions 1 to 60 of SEQ ID NO: 1, positions 1 to 60 of SEQ ID NO: 5, positions 1 to 57 of SEQ ID NO: 9, positions 1 to 57 of SEQ ID NO: 13, SEQ ID NO: 43, SEQ ID NO: 45, and SEQ ID NO: 47.

15. The method according to claim 14 , wherein the polynucleotide containing the polynucleotide consisting of a nucleotide sequence encoding a secretory signal peptide consists of a nucleotide sequence set forth in any of SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 5, SEQ ID NO: 6, and SEQ ID NOS: 17 to 19.

16. The method according to claim 12 , wherein the polynucleotide is inserted into an expression vector.

17. The method according to claim 12 , wherein the transformed cell is a transformed bacterium or transformed yeast.

18. The method according claim 12 , wherein the mogroside having at least one β-1,6-glucoside bond further has at least one β-1,2-glucoside bond.

19. The method according to claim 18 , wherein the mogroside having at least one β-1,6-glucoside bond and at least one β-1,2-glucoside bond is selected from mogroside V, siamenoside I, mogroside IV, and mogroside IIIA 1 .

20. The method according to claim 12 , wherein the mogroside having no β-1,6-glucoside bond is selected from mogroside IIIE and mogroside IIA.

21. The method according to claim 1 , wherein the protein (b) is selected from the group consisting of SEQ ID NO: 4 and SEQ ID NO: 8, wherein 1 to 14 amino acids have been deleted, substituted, inserted, and/or added, and having an activity to cleave a β-1,6-glucoside bond of a mogroside.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 18, 2017
From: OCHIAI, MISA; ONO, EIICHIRO
To: SUNTORY HOLDINGS LIMITED
Reel/Frame 043034/0509 →
Priority Claims (1)
JP 2015-008508 · Jan 20, 2015 · national
Continuity (1)
Related Publication 20180010160A1 · Jan 11, 2018